Entheon Biomedical Corp ENTBF

$0.06 +0.05 (1,072.55%)

Valuation

Market cap
—
Revenue TTM
$0
Net income TTM
$0
P/E (trailing)
—
P/E (forward)
—
Profit margin
0.00%
Debt to equity
—

Trading

Volume
1,900
Avg volume
—
Day's range
$0.03 – $0.06
Shares out
—
Stochastic %K
100%
Beta
—
Analysts
—
Price target
—

Price

Company profile

Entheon Biomedical Corp. operates as a biotechnology research and development company. It develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
604-562-3932
Website
https://entheonbiomedical.com
Address
999 West Broadway, Suite 720, Vancouver, Canada

Latest news

No headlines yet.